Preclinical studies comparing different bispecific antibodies for redirecting T cell cytotoxicity to extracellular antigens on prostate carcinomas.

Source:http://linkedlifedata.com/resource/pubmed/id/15816517

Download in:

View as

General Info

PMID
15816517